Can Covid-19 increase the risk of developing Parkinson’s?

News

Author: Caithlin NgPublished: 21 May 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Parkinson’s could be caused or modulated by infections like Covid-19, a new study suggests – though more evidence is needed to draw a definitive conclusion.

As part of the study, researchers from the Federal University of São Paulo, Brazil, drew on previous findings to support their hypothesis. For example, studies in mice have found that infection with some strains of influenza could cause neural changes similar to those in Parkinson’s.

Furthermore, people born during or around the 1918 influenza pandemic were over twice as likely to develop Parkinson’s than those born in the decades before or after.

Patrik Brundin, co-editor-in-chief of the Journal of Parkinson’s Disease, said that while it’s “too early to know what the long-term consequences of Covid-19 will be on the brain, the clinical psychiatry and neurology research communities definitely need to be vigilant in monitoring how those who recover from moderate and severe Covid-19 fare in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.


Read more:

New Parkinson’s trial platform could “dramatically speed up the search for a cure”

Can higher levels of caffeine and uric acid prevent Parkinson’s?

Go Back

Share this story

Comments


Related articles


Parkinson's neurology deep brain stimulation

sponsored article

Advances

Deep brain stimulation: the future is personalised

Two experts on how “dual targeting” is changing DBS treatment for Parki

READ MORE
Film writer, director and professor Brett Harvey poses for a photo.

Interviews

The film that’s helping people to process their Parkinson’s disease diagnosis

We speak to director Brett Harvey about his latest project

READ MORE

Interviews

“There is something marvellous about taking control of our lives”

Jo Yaldren on her ‘Year of Yes’ with Parkinson’s disease

READ MORE